Home › Funds › Farallon Capital Management › GERN
Farallon Capital Management position in GERN
GERON CORP · Health Care
Latest position (Q2 2026)14.40K sh
Reported value held$18.43K
Portfolio Weight0.00%
First reportedQ1 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 7.50M | $24.73M | New |
| Q2 2024 | 16.84M | $71.39M | Add |
| Q3 2024 | 43.00K | $195.22K | Reduce |
| Q4 2024 | 43.00K | $152.22K | Hold |
| Q1 2025 | 43.00K | $68.37K | Hold |
| Q2 2025 | 43.00K | $60.63K | Hold |
| Q3 2025 | 43.00K | $58.91K | Hold |
| Q4 2025 | 43.00K | $56.76K | Hold |
| Q1 2026 | 43.00K | $64.07K | Hold |
| Q2 2026 | 14.40K | $18.43K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding GERN
- BlackRock Inc 49.12M sh · $62.87M · Q2 2026
- Vanguard Group 35.66M sh · $47.07M · Q4 2025
- Citadel Advisors 29.55M sh · $37.83M · Q2 2026
- Goldman Sachs Group 16.63M sh · $21.29M · Q2 2026
- Geode Capital Management 14.56M sh · $18.64M · Q2 2026
- Morgan Stanley 12.95M sh · $16.57M · Q2 2026
- Millennium Management 8.11M sh · $10.38M · Q2 2026
- Fidelity Management & Research (FMR) 5.50M sh · $7.04M · Q2 2026
- Northern Trust Corp 5.03M sh · $6.44M · Q2 2026
- UBS Group AG 4.90M sh · $6.27M · Q2 2026
- Renaissance Technologies 4.58M sh · $5.86M · Q2 2026
- Two Sigma Investments 4.31M sh · $5.51M · Q2 2026